Literature DB >> 18451703

Cortical pathology in multiple sclerosis.

Christine Stadelmann1, Monika Albert, Christiane Wegner, Wolfgang Brück.   

Abstract

PURPOSE OF REVIEW: Multiple sclerosis is the most common chronic, disabling central nervous system disease in young adults, characterized by inflammatory demyelinating white matter lesions with glial scar formation and axonal loss. Lately, evidence has accumulated that large areas of grey matter are affected in multiple sclerosis patients. RECENT
FINDINGS: Findings in post-mortem brain tissue support the notion that cortical demyelination is frequent and extensive, especially in patients with chronic multiple sclerosis. Cortical lesions differ from white matter lesions with respect to inflammatory cell infiltration, gliosis, and remyelination. Thus, differences in cortical and white matter lesion pathogenesis have been proposed. Experimental models suggest a decisive role for antimyelin antibodies in cortical demyelination. Topical studies focus on damage to neurons, dendrites, and synapses in cortical multiple sclerosis lesions. Improved imaging techniques for the detection of cortical lesions are currently developed and will provide the basis for future clinicopathological correlative studies.
SUMMARY: In summary, recent years have opened our eyes to the extensive grey matter involvement in multiple sclerosis. Studies on the pathogenesis of cortical demyelination, cortical damage, and repair will elucidate basic principles of multiple sclerosis lesion formation. However, more sensitive imaging tools are required to study the impact of cortical lesions on clinical symptoms, disability, and disease progression.

Entities:  

Mesh:

Year:  2008        PMID: 18451703     DOI: 10.1097/01.wco.0000318863.65635.9a

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  39 in total

1.  T1 and proton density at 7 T in patients with multiple sclerosis: an initial study.

Authors:  Katharine T Bluestein; David Pitt; Michael V Knopp; Petra Schmalbrock
Journal:  Magn Reson Imaging       Date:  2011-09-19       Impact factor: 2.546

2.  In vivo evidence of disseminated subpial T2* signal changes in multiple sclerosis at 7 T: a surface-based analysis.

Authors:  J Cohen-Adad; T Benner; D Greve; R P Kinkel; A Radding; B Fischl; B R Rosen; C Mainero
Journal:  Neuroimage       Date:  2011-04-13       Impact factor: 6.556

Review 3.  The emerging role of microRNAs in multiple sclerosis.

Authors:  Andreas Junker; Reinhard Hohlfeld; Edgar Meinl
Journal:  Nat Rev Neurol       Date:  2010-12-14       Impact factor: 42.937

Review 4.  Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.

Authors:  Ranjan Dutta; Bruce D Trapp
Journal:  Prog Neurobiol       Date:  2010-10-12       Impact factor: 11.685

5.  Clinical trials in multiple sclerosis: current and future requirements - potential pitfalls.

Authors:  P Rieckmann
Journal:  J Neurol       Date:  2008-12       Impact factor: 4.849

Review 6.  Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlates.

Authors:  Jeremy D Schmahmann; Eric E Smith; Florian S Eichler; Christopher M Filley
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

7.  NG2 cells in white matter but not gray matter proliferate in response to PDGF.

Authors:  Robert A Hill; Kiran D Patel; Jelena Medved; Alex M Reiss; Akiko Nishiyama
Journal:  J Neurosci       Date:  2013-09-04       Impact factor: 6.167

8.  In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI.

Authors:  Caterina Mainero; T Benner; A Radding; A van der Kouwe; R Jensen; B R Rosen; R P Kinkel
Journal:  Neurology       Date:  2009-07-29       Impact factor: 9.910

Review 9.  Seizures in patients with multiple sclerosis: epidemiology, pathophysiology and management.

Authors:  Brendan J Kelley; Moses Rodriguez
Journal:  CNS Drugs       Date:  2009-10       Impact factor: 5.749

10.  The left superior temporal gyrus is a shared substrate for auditory short-term memory and speech comprehension: evidence from 210 patients with stroke.

Authors:  Alexander P Leff; Thomas M Schofield; Jennifer T Crinion; Mohamed L Seghier; Alice Grogan; David W Green; Cathy J Price
Journal:  Brain       Date:  2009-12       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.